Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

CGRP - Exploring Peptides

Calcitonin Gene-Related Peptide (CGRP) is a neuropeptide primarily involved in regulating vascular tone and nociception (pain signaling). It exists in two isoforms: α-CGRP, predominantly found in the nervous system, and β-CGRP, present in the enteric nervous s

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Calcitonin Gene-Related Peptide (CGRP) is a neuropeptide primarily involved in regulating vascular tone and nociception (pain signaling). It exists in two isoforms: α-CGRP, predominantly found in the nervous system, and β-CGRP, present in the enteric nervous system. CGRP is released from sensory neurons and plays a significant role in dilating blood vessels and transmitting pain. It is a central target in research related to migraine, cardiovascular function, and other neurological conditions. CGRP's effects on the cardiovascular system and pain pathways have led to the development of drugs aimed at treating migraine and other vascular-related disorders.

Category

Neuropeptide

Sequence

Ser-Leu-Gly-Thr-Gly-Thr-Phe-Thr-Asp-Leu-Arg-His-Val-Lys-Asn-Thr-Ala-Thr-Cys-Val-Thr-Arg-Thr-Tyr-Gly-Ser-Leu-Asp-Lys-Lys-Cys-Gly-Thr-Lys-Met

Molecular Weight

Approximately 3,797.2 Da (Daltons) for α-CGRP

Molecular Formula

C176H282N52O52S2

Most Common Uses:

Migraine Treatment: CGRP plays a critical role in migraine pathophysiology by causing vasodilation of cerebral blood vessels and transmitting pain signals. Blocking CGRP receptors or inhibiting CGRP release is effective in preventing migraines. Monoclonal antibodies and CGRP receptor antagonists (gepants) have been developed for this purpose.

Cardiovascular Regulation: CGRP is one of the most potent vasodilators in the human body, and it is involved in maintaining vascular homeostasis. It acts to widen blood vessels, lowering blood pressure, and regulating blood flow in various tissues. This has implications for treating cardiovascular conditions such as hypertension and heart failure.

Pain Signaling: CGRP is involved in the transmission of pain signals from peripheral nerves to the central nervous system. It is released in response to noxious stimuli and plays a role in sensitizing pain pathways, making it a target for pain-relief therapies beyond migraines.

Bone and Tissue Repair: CGRP has been shown to promote bone formation and healing, as it stimulates osteoblast activity. This suggests potential therapeutic applications in bone-related conditions like osteoporosis and fracture recovery.

Gastrointestinal Function: CGRP is present in the enteric nervous system and influences gastrointestinal functions, including motility and fluid secretion. It may play a role in gastrointestinal disorders related to dysregulation of these processes.

Warnings and Cautions:

Medical Supervision: CGRP-targeted therapies, especially those used for migraine, should be administered under medical supervision, as they can influence cardiovascular function.

Side Effects: Potential side effects of CGRP inhibitors or receptor antagonists include nausea, constipation, and injection site reactions. Long-term cardiovascular effects are also under investigation.

Contraindications: Caution is advised in individuals with cardiovascular diseases, as blocking CGRP could affect blood pressure regulation and vascular function.

Dosages:

Migraine Treatment:

Gepants and Monoclonal Antibodies: CGRP inhibitors, such as gepants (oral CGRP receptor antagonists) and CGRP monoclonal antibodies, are typically administered in doses based on the specific drug. Gepants like ubrogepant and rimegepant are taken orally, while monoclonal antibodies like erenumab, fremanezumab, and galcanezumab are administered subcutaneously on a monthly or quarterly basis, depending on the formulation.

Experimental Research:

Variable Dosing: In research settings, CGRP is often administered in doses that vary according to the study design and specific focus, whether it’s for understanding its role in pain transmission, vascular function, or bone health.

Mechanism of Action:

CGRP exerts its effects by binding to the calcitonin receptor-like receptor (CRLR) and its co-receptor, receptor activity-modifying protein 1 (RAMP1). Once bound, CGRP activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) and subsequent vasodilation. This vasodilatory effect is significant in migraine pathophysiology, where CGRP release in the trigeminovascular system leads to dilation of intracranial blood vessels, contributing to headache pain. By blocking the CGRP pathway, drugs can reduce vasodilation and pain transmission.

Benefits:

Migraine Relief: CGRP inhibitors have revolutionized migraine treatment by targeting a root cause of migraine-related pain—vasodilation and pain signal transmission in the brain.

Cardiovascular Health: CGRP’s role in vasodilation and blood pressure regulation makes it a key player in maintaining vascular health. However, caution is needed when manipulating this system, particularly in patients with preexisting cardiovascular conditions.

Pain Management: Beyond migraine, CGRP’s role in nociception presents opportunities for developing novel pain management strategies, especially for chronic pain conditions.

Bone Regeneration: CGRP’s stimulation of osteoblasts and promoting bone health suggest its use in treatments for osteoporosis and bone healing.

Closing:

Calcitonin Gene-Related Peptide (CGRP) is a powerful neuropeptide with widespread effects on vascular tone, pain transmission, and bone health. Its involvement in migraine pathophysiology has led to the development of CGRP-targeted therapies that provide significant relief for individuals with migraines. CGRP also has potential applications in pain management, cardiovascular health, and bone regeneration. As research continues to explore CGRP’s broader role in physiological regulation, it remains a promising target for future therapeutic interventions.

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Case Studies and Success Stories

Real-life success stories of peptides for mental health illuminate the potential benefits of peptide therapy for mental health. On various online platforms, such as message boards and Reddit, individuals have shared their experiences, providing anecdotal evidence of positive outcomes. Some users have experienced a noticeable improvement in their mood and a reduction in anxiety after incorporating peptide therapy into their routine.11 Others have highlighted the impact of peptide therapy on cognitive function and observed enhanced focus and better memory recall, leading to improved productivity in their work and personal life.12 These users often credited these benefits to the inclusion of peptides in their mental health regimen. While these stories offer insights into the potential advantages of peptide therapy, it’s crucial to approach them with a discerning eye. Anecdotal evidence, while valuable, does not replace Scientific Research. Each individual’s response to peptide therapy can vary, and what works for one may not work the same way for another.

Source: driphydration.com ↗

Featured Articles & Research

Sermorelin Guide: Benefits, Side Effects, Dosage & More SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332 Adalank vs Selank: Differences, Benefits and Effects

Source: exploring-peptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosages:

For Pancreatic Health Support: The typical dosage of Pancragen is based on clinical protocols involving short treatment cycles. It is often administered orally or intramuscularly at doses determined by a healthcare provider, depending on the severity of the condition being treated. Cycle Length: Pancragen is usually administered in short cycles, often lasting from 10 days to 1 month. Longer cycles are not commonly recommended due to the need for periodic reassessment of the patient’s condition and treatment effects.

Source: exploring-peptides.com ↗
Potential benefits

Benefits:

Rapid Hypoglycemia Reversal: Glucagon provides fast relief for individuals experiencing severe hypoglycemia, which is particularly crucial for people with diabetes who rely on insulin therapy. Gastrointestinal Relaxation: In diagnostic settings, glucagon effectively relaxes the smooth muscles of the gastrointestinal tract, aiding in imaging and examination. Potential for Weight Management: Ongoing research suggests that glucagon could play a role in regulating appetite and energy expenditure, providing potential benefits for weight loss and obesity management.

Source: exploring-peptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →